In the same study, a sequential increase of PHGDH expression in patients with early and late AD pathology was reported in hippocampus and prefrontal cortex: the increase in PHGDH expression correlated with progression of clinical symptoms and worsening cognitive decline. The gene discussed is PHGDH; the disease is Alzheimer disease.